No Data
No Data
Form 144 | Recursion Pharmaceuticals(RXRX.US) Director Proposes to Sell 202.93K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake intends to sell 20,054 shares of its common stock on May 14, with a total market value of approximately $20
Express News | Recursion Pharmaceuticals Shares Are Trading Higher Possibly Amid Strength in High-short Interest Stocks After Retail Trader 'Roaring Kitty' Returned to Social Media. The Stock May Also Be Moving Amid Continued Strength After the Company Announced on...
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday.Shares of Sony Group Corporation (NYSE:SONY) rose sharply during Tuesday's session after the company reported better-tha
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)
Express News | Recursion Announces Completion of Nvidia-Powered Biohive-2, the Largest Supercomputer in Pharmaceutical Industry
Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) made waves Monday with the announcement of the completion of its groundbreaking BioHive-2 supercomputer, as well as the notable surge in its stock that fo